FDA Citizen Petition Proposal Inhibits OTC Drug Review Process - CTFA
This article was originally published in The Rose Sheet
Executive Summary
An FDA proposal to ban citizen petitions on pending regulations "appears to preclude the introduction of new data and information in the OTC drug review," the Cosmetic, Toiletry and Fragrance Association argues in Feb. 28 comments.
You may also be interested in...
OTC Drug Labeling Implementation Date Extended One Year To 2002
FDA is extending the OTC drug labeling implementation date to May 2002 to allow time for the agency to develop "forthcoming guidances" regarding a number of outstanding concerns from trade organizations.
Citizen Petitions May Not Preempt Agency Action Under FDA Proposed Rule
Pending FDA actions cannot be the subject of a "citizen petition" submitted to the agency, a proposed rule published in the Nov. 30 Federal Register directs.
FDA Extends Sunscreen Monograph Implementation Date To December 2002
FDA will delay the effective date of the OTC sunscreen final monograph a year-and-a-half, following a request from the Cosmetic, Toiletry and Fragrance Association, the agency says in an Oct. 1 letter to the trade group.